KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
3.800
+0.130 (3.54%)
At close: Jul 8, 2025, 4:00 PM
3.980
+0.180 (4.73%)
After-hours: Jul 8, 2025, 5:42 PM EDT
KORU Medical Systems Market Cap
KORU Medical Systems has a market cap or net worth of $175.34 million as of July 8, 2025. Its market cap has increased by 71.73% in one year.
Market Cap
175.34M
Enterprise Value
170.33M
1-Year Change
71.73%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since December 1, 1998, KORU Medical Systems's market cap has increased from $1.00M to $175.34M, an increase of 17,433.58%. That is a compound annual growth rate of 21.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 7, 2025 | 169.30M | -4.08% |
Dec 31, 2024 | 176.50M | 57.45% |
Dec 29, 2023 | 112.10M | -30.63% |
Dec 30, 2022 | 161.60M | 20.87% |
Dec 31, 2021 | 133.70M | -49.45% |
Dec 31, 2020 | 264.50M | 2.56% |
Dec 31, 2019 | 257.90M | 322.09% |
Dec 31, 2018 | 61.10M | 28.90% |
Dec 29, 2017 | 47.40M | 150.79% |
Dec 30, 2016 | 18.90M | -9.57% |
Dec 31, 2015 | 20.90M | 16.76% |
Dec 31, 2014 | 17.90M | 123.75% |
Dec 31, 2013 | 8.00M | -4.76% |
Dec 31, 2012 | 8.40M | -16.00% |
Dec 30, 2011 | 10.00M | 104.08% |
Dec 31, 2010 | 4.90M | -27.94% |
Dec 31, 2009 | 6.80M | 7.94% |
Dec 31, 2008 | 6.30M | 1.61% |
Dec 31, 2007 | 6.20M | 313.33% |
Dec 29, 2006 | 1.50M | -50.00% |
Dec 30, 2005 | 3.00M | 20.00% |
Dec 31, 2004 | 2.50M | 177.78% |
Dec 31, 2003 | 900.00K | 28.57% |
Dec 31, 2002 | 700.00K | -70.83% |
Dec 31, 2001 | 2.40M | -36.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 698.13B |
Johnson & Johnson | 374.84B |
AbbVie | 335.21B |
Novo Nordisk | 313.36B |
UnitedHealth Group | 279.13B |
Novartis AG | 240.15B |
Abbott Laboratories | 232.02B |
AstraZeneca | 217.48B |